KalVista Pharmaceuticals, Inc.
KALV
$13.55
-$0.05-0.37%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 253.20M | 135.78M | 174.27M | 210.40M | 75.59M |
| Total Receivables | 9.40M | 12.93M | 12.29M | 10.87M | 23.68M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.75M | 3.56M | 5.07M | 4.42M | 4.84M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 267.36M | 152.27M | 191.63M | 225.69M | 104.10M |
|
|
|||||
| Total Current Assets | 267.36M | 152.27M | 191.63M | 225.69M | 104.10M |
| Net Property, Plant & Equipment | 7.25M | 7.90M | 7.96M | 9.15M | 9.47M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.39M | 662.00K | 605.00K | 567.00K | 397.00K |
| Total Assets | 275.99M | 160.83M | 200.20M | 235.40M | 113.97M |
|
|
|||||
| Total Accounts Payable | 5.86M | 5.20M | 10.79M | 9.11M | 3.10M |
| Total Accrued Expenses | 18.32M | 15.43M | 10.36M | 12.40M | 14.84M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.44M | 1.54M | 1.26M | 1.30M | 1.19M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 25.62M | 22.16M | 22.41M | 22.81M | 19.13M |
|
|
|||||
| Total Current Liabilities | 25.62M | 22.16M | 22.41M | 22.81M | 19.13M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.34M | 4.68M | 4.99M | 6.02M | 6.26M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 100.91M | -- | -- | -- | -- |
| Total Liabilities | 130.87M | 26.84M | 27.40M | 28.82M | 25.39M |
|
|
|||||
| Common Stock & APIC | 748.28M | 689.13M | 685.84M | 679.80M | 516.95M |
| Retained Earnings | -600.95M | -552.44M | -510.17M | -469.73M | -425.08M |
| Treasury Stock & Other | -2.21M | -2.70M | -2.87M | -3.49M | -3.29M |
| Total Common Equity | 145.13M | 133.99M | 172.80M | 206.58M | 88.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 145.13M | 133.99M | 172.80M | 206.58M | 88.58M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 145.13M | 133.99M | 172.80M | 206.58M | 88.58M |
|
|
|||||